Revenue grew 7% year-over-year to $157M, with adjusted EBITDA margin at 48% and strong AI adoption driving new business across pharma and hospital segments. Full-year guidance was raised, and AI Search and Scribe products are fueling growth and deeper client engagement.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.